Investigational Site Number :2500002

Paris 75019

2 studies enrolling now · 7 studies all time

What they study most

Asthma, Atopic Dermatitis, Colorectal Cancer, Gastric Cancer, Glycogen Storage Disease Type II-Pompe's Disease, Hepatocellular Carcinoma, Metastatic Neoplasm, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma, Polycystic Kidney, Autosomal Dominant, Type 1 Diabetes Mellitus, Wheezing

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now
• Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) — Recruiting now
• A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) — Completed
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" — Completed
• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early
• A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients — Stopped early